Status of novel drug delivery technology for phytotherapeutics

Expert Opinion on Drug Delivery

Volumn 6, Issue 6, 2009, Pages 625-637

  Musthaba, S Mohamed ^a   Baboota, Sanjula ^a   Ahmed, Sayeed ^a   Ahuja, Alka ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cardiac stents; Herbal medicines; Liposomes; Matrix system; Microemulsion; Polymer conjugation; Polymeric nanoparticles; Proliposomes; Solid dispersions; Solid lipid nanoparticles; Tissue engineering; Transdermal patches

Indexed keywords

BREVISCAPINE; CAMPTOTHECIN; CATECHIN; CURCUMIN; CUSCUTA CHINENSIS EXTRACT; GUARANA EXTRACT; HERBACEOUS AGENT; HYPERICIN; KHELLIN; LIPOSOME; NANOPARTICLE; PACLITAXEL; PODOPHYLLOTOXIN; POLYMER; PROLIPOSOME; PSORALEN; RAPAMYCIN; SILYMARIN; SOLID LIPID NANOPARTICLE; TETRANDRINE; TRIPTOLIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ALOPECIA; ANEMIA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BLOOD TOXICITY; CARDIOTOXICITY; CHEMOPROPHYLAXIS; CONJUGATION; DIARRHEA; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG HALF LIFE; DRUG SOLUBILITY; FATIGUE; GASTROINTESTINAL TOXICITY; GEL; HERBAL MEDICINE; HUMAN; IN-STENT RESTENOSIS; LIPOPHILICITY; LIPOSOMAL DELIVERY; LIVER INJURY; LIVER TOXICITY; MICROEMULSION; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; PHOTOCHEMOTHERAPY; PHYTOTHERAPY; RASH; REVIEW; SKIN TOXICITY; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; TISSUE ENGINEERING; TRANSDERMAL PATCH; VOMITING;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; EMULSIONS; GELS; HUMANS; LIPOSOMES; NANOPARTICLES; PHYTOTHERAPY; POLYMERS; TABLETS; TISSUE ENGINEERING;

EID: 67649159294     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240902980154     Document Type: Review

References (83)

1. Solecki RS, Shanidar IV. A neanderthal flower burial in northern iraq. Science 1975;190:880-881
2. Saklani A, Kutty SK. Plant-derived compounds in clinical trials. Drug Discov Today 2007;13:161-171
3. Cardellina JH. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod 2000;65:1073-1084
4. Ilya R, David MR, Slavko K, Nebojsa I, et al. Plant and human health in the twenty-first century. Trends Biotechnol 2002;20:522-531 (Pubitemid 35356407)
5. Lu C, Lu Y, Chen J, et al. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. Eur J Pharm Biopharm 2007;66:210-219 •• Details about development of sustained drug release of herbal medicines. (Pubitemid 46654778)
6. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine 2001;8:401-409 (Pubitemid 32983062)
7. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004;303:1818-1822 (Pubitemid 38374867)
8. Kostarelos K. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science. Adv Colloid Interface Sci 2003;106:147-168
9. Ratnam DV, Ankola DD, Bhardwaj V, et al. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 2006;113:189-207 (Pubitemid 43983041)
10. Allemann E, Gurny R, Doelker E. Drug loaded nanoparticles: preparation methods and drug targeting issues. Eur J Pharm Biopham 199;39:173-191
11. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Del Rev 2002;54:631-651 (Pubitemid 35247520)
12. Sahu A, Bora U, Kasoju N, Goswami P. Synthesis of novel biodegradable and self-assembling methoxy poly (ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomaterialia 2008;4:1752-1761
13. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin. A short review. Life Sci 2006;78:2081-2087
14. Hachida HLM, Enosawa S, Suzuki XKLS, Koyanagi H. immunosuppressive effect of triptolide in vitro. Transplant Proc 1999;3:2056-2057 (Pubitemid 29376525)
15. Zheng YL, Lin JF, Lin CC, Xu Y. Anti-inflammatory effect of triptolide. Zhongguo Yaoli Xuebao 1994;15:540-543 (Pubitemid 24342520)
16. Gang YY, Zhang ZX. Progress in pharmacological study of Tripterygium wilfordii and its active compounds. J China Pharm Univ 1995;26:252-256
17. Liu M, Dong J, Yang Y, et al. Anti-inflammatory effects of triptolide loaded poly (d,l-lactic acid) nanoparticles on adjuvant-induced arthritis in rats. J Ethnopharmacology 2005;97:219-225 (Pubitemid 40222021)
18. Min KH, Park K, Kim YS, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008;127:208-218
19. Ertl B, Platzer P, Wirth M, Gabora F. Poly (D, L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J Control Release 1999;61:305-317
20. Labouebe ZM, Lange N, Gurny R, Delie F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm 2006;326:174-181 (Pubitemid 44647750)
21. Yen FL, Wu TH, Lin LT, et al. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem Toxicol 2008;46:1771-1777
22. Yen FL, Wu TH, Lin LT, Lin CC. Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminopheninduced hepatotoxicity in rats. J Ethnopharmacol 2007;111:123-128 (Pubitemid 46482888)
23. Nisa M, Akbar S, Tariq M, Hussain Z. Effect of Cuscuta chinensis water extract on 7, 12-dimethylbenz [a] anthracene-induced skin papillomas and carcinomas in mice. J Ethnopharmacol 1986;18:21-31
24. Umehara K, Nemoto K, Ohkubo T, et al. isolation of a new 15-membered macrocyclic glycolipid lactone, Cuscutic Resinoside a from the seeds of Cuscuta chinensis: a stimulator of breast cancer cell proliferation. Planta Medica 2004;70:299-304
25. Liu JH, Jiang B, Bao YM, An LJ. Effect of Cuscuta chinensis glycoside on the neuronal differentiation of rat pheochromocytoma PC12 cells. Int J Dev Neurosci 2003;21:277-281 (Pubitemid 36870747)
26. Zheng HZ, Dong ZH, She J. Modern study of traditional Chinese medicine, first edition. Beijing Xue Yuan Press, People's Republic of China, Beijing; 1998. p. 4110-4120
27. Bao X, Wang Z, Fang J, Li X. Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis. Planta Med 2002;68:237-243 (Pubitemid 34270992)
28. Zhang L, Kosaraju SL. Biopolymeric delivery system for controlled release of polyphenolic antioxidants. Eur Poly J 2007;4:32956-32966
29. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol 2004;500(1-3):177-185 (Pubitemid 39310504)
30. Record IR, Lane JM. Simulated intestinal digestion of green and black teas. Food Chem 2001;73(4):481-486 (Pubitemid 32433390)
31. Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 2006;308:140-148 (Pubitemid 43097245)
32. Samaligy MS, Afifi NN, Mahmoud EA. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int J Pharm 2006;319:121-129 (Pubitemid 44051811)
33. Johnston MJW, Semple SC, Klimuk SK, et al. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochimica et Biophysica Acta 2006;1758:55-64 (Pubitemid 44262108)
34. Sou K, Inenaga S, Takeoka S, Tsuchida E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int J Pharm 2008;352:287-293
35. Fang JY, Hwang TL, Huanga YL, Fang CL. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006;310:131-138 (Pubitemid 43287976)
36. Lee JS, Chungb D, Lee HG. Preparation and characterization of calcium pectinate gel beads entrapping catechin-loaded liposomes. Int J Biol Macromol 2008;42:178-184
37. Payne NI, Timmis P, Ambrose CV, Warel MD. Proliposomes: a novel solution to an old problem. J Pharm Sci 1986;75:325-329
38. Mayer LD, Baly MB, Hope KJ, Cullis PR. Techniques for encapsulating bioactive agents into liposomes. Chem Phys lipids 1986;40:333-345 (Pubitemid 16040787)
39. Yan-yu X, Yun-Mei S, Zhi-Peng C, I-Neng P. Preparation of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 2006;319:162-168 (Pubitemid 44051803)
40. Barzaghi N, Crema F, Gatti G, et al. Pharmacokinetic studies on idB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet 1990;15:333-338
41. Morazzoni P, Magistretti MJ, Giachetti C, Zanolo G. Comparative bioavailability of silipide, a new flavanolignan complex, in rats. Eur J Drug Metab Pharmacokinet 1992;17:39-44
42. Wong HL, Bendayan R, Rauth AM, et al. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 2007;5:491-504 (Pubitemid 47259227)
43. Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 2007;337:299-306 (Pubitemid 46756048)
44. Li Y, Dong L, Jia A, et al. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromolecules 2006;38:296-299
45. Mei Z, Chen H, Weng T, et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003;56:189-196 (Pubitemid 37072102)
46. Mei Z, Li X, Wu Q, et al. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Pharmacol Res 2005;51:345-351 (Pubitemid 40430808)
47. Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110:296-306 (Pubitemid 41827483)
48. Lawrencea MJ, Reesb GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121 (Pubitemid 30943127)
49. Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 2004;98:427-436 (Pubitemid 39093953)
50. Ali J, Akhtar N, Sultana Y, et al. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp Clin Pharmacol 2008;30:1-9 •• First article to show herbal oil microemulsion.
51. Wang X, Jiang Y, Wang YW, et al. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem 2008;108:419-424
52. Save T, Venkitachalam P. Studies on solid dispersions of nifedipine. Drug Dev Ind Pharm 1992;18:1663-1679
53. Ginés JM, Arias MJ, Moyano JR, Soto PJS. Thermal investigation of crystallization of poly (ethylene glycol)s in solid dispersions containing oxazepam. Int J Pharm 1996;143:247-253 (Pubitemid 26425830)
54. Chen Y, Zhang GG, Neilly J, et al. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm 2004;286:69-80 (Pubitemid 39410474)
55. Law D, Wang W, Schmitt EA, et al. Properties of rapidly dissolving eutectic mixtures of poly (ethylene glycol) and Fenofibrate: the eutectic microstructure. J Pharm Sci 2003;92:505-515 (Pubitemid 36258965)
56. Chiou WL, Riegelman S. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J Pharm Sci 1969;58:1505-1510
57. Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1-10 (Pubitemid 38293005)
58. Sun N, Wei X, Wu B, et al. Enhanced dissolution of silymarin/ polyvinylpyrrolidone solid dispersion, pellets prepared by a one-step fluid-bed coating technique. Powder Technol 2008;182:72-80 (Pubitemid 351173199)
59. Marconi B, Mancini F, Colombo P, et al. Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Release 1999;60:261-268 (Pubitemid 29335951)
60. Heard CM, Johnson S, Mossb G, Thomasa CP. In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana. Int J Pharm 2006;317:26-31
61. Hoeven B, Pires N, Warda H, et al. Drug-eluting stents: results, promises and problems. Int J Cardiol 2005;99:9-17 (Pubitemid 40261018)
62. Bruce KD, Gerard L, Warren L, et al. Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent. Coronary Artery Dis 2002;13:183-188 (Pubitemid 34747967)
63. Axel DI, Kunert W, Göggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-645 (Pubitemid 27329445)
64. Sousa JE, Costa MA, Sousa AGMR, et al. Two year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107:381-383 (Pubitemid 36158039)
65. Scheerder IK, Wilczek KL, Verbeken EV, et al. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995;114:105-114
66. Rechavia E, Litvack F, Fishbien MC, et al. Biocompatibility of polyurethane-coated stents: tissue and vascular aspects. Catheter Cardio Diag 1998;45:202-207 (Pubitemid 28450222)
67. Pan CJ, Tang JJ, Weng YJ, et al. Preparation, characterization and anticoagulation of curcumin-eluting, controlled biodegradable coating stents. J Control Release 2006;116:42-49 •• Details about development of cardiac stents for sustained drug release of herbal medicines for the treatment of in-stent restenosis. (Pubitemid 44792298)
68. Sriamornsak, Thirawong P, Korkerd N, Swelling K. Erosion and release behaviour of alginate-based matrix tablets. Eur J Pharm Biopharm 2007;66:435-450
69. Martinez IJ, Barreda TQ, Robles LV. Sustained delivery of captopril from floating matrix tablets. Int J Pharm 2008;362:37-43
70. Adeyeye CM, Price JC. Development and evaluation of sustained release ibuprofen-wax microspheres. ii. in vitro dissolution studies. Pharm Res 1994;11:575-579 (Pubitemid 24144453)
71. Papkov MS, Agashi K, Olaye A, et al. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:187-206 (Pubitemid 46887622)
72. Saltzman WM, Olbricht WL. Building drug delivery into tissue engineering. Nat Rev Drug Discov 2002;1:177-186 (Pubitemid 37361421)
73. Yan AX, Jun Y, Min W, et al. Preparation of chitosan-gelatin scaffold containing tetrandrine-loaded nano-aggregates and its controlled release behavior. Int J Pharm 2008;350:257-264 •• Demonstrates the use of herbal drug in tissue engineering.
74. Caiolfa VR, Zamai M, Fiorino A, et al. Polymer-bound camptothecin: initial biodistribution and antitumour activity studies. J Control Release 2000;65:105-119 (Pubitemid 30122920)
75. Greenwald RB, Conover CD, Pendri A, et al. Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan, podophyllotoxin. J Control Release 1999;61:281-294 (Pubitemid 29413023)
76. Mi FL, Tan YC, Liang HF, Sung HW. in vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 2002;23:181-191 (Pubitemid 33041353)
77. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today 2007;12:23-24 •• Details about different naturally occurring terpenes as permeation enhancer in transdermal drug delivery. (Pubitemid 350180560)
78. Tokudome Y, Oku N, Doi K, et al. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma. Biochimica et Biophysica Acta 1996;1279:70-74 (Pubitemid 26067419)
79. Zhigaltsev IV, Maurer N, Akhong QF, et al. Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retention. J Control Release 2005;104:103-111 (Pubitemid 40615239)
80. Zhong H, Deng Y, Wang X, Yang B. Multivesicular liposome formulation for the sustained delivery of breviscapine. Int J Pharm 2005;301:15-24 (Pubitemid 41206586)
81. Zhang L, Hu Y, Jiang X, et al. Camptothecin derivative-loaded poly (caprolactone-co-lactide)- b-PEG-b-poly (caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 2004;96:135-148 (Pubitemid 38438496)
82. Williams J, Lansdown R, Sweitzer R, et al. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitor. J Control Release 2003;91:167-172 (Pubitemid 37288887)
83. Zeng XM, Martin GP, Marriott C. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. Eur J Pharm Sci 1995;3:87-93